---
title: "ADXS.US (ADXS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADXS.US/news.md"
symbol: "ADXS.US"
name: "ADXS.US"
parent: "https://longbridge.com/en/quote/ADXS.US.md"
datetime: "2026-03-13T20:26:41.168Z"
locales:
  - [en](https://longbridge.com/en/quote/ADXS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADXS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADXS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ADXS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ADXS.US/news.md)


# ADXS.US (ADXS.US) — Related News

### [OS Therapies Provides Global Regulatory Update for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metstatic Osteosarcoma | OSTX Stock News](https://longbridge.com/en/news/276114753.md)
*2026-02-17T03:00:00.000Z*
> OS Therapies Inc. (NYSE American: OSTX) has provided a global regulatory update for its immunotherapy OST-HER2, aimed at

### [Ayala Unit to Buy Majority Stake in Cold Storage Provider Megafridge](https://longbridge.com/en/news/273665726.md)
*2026-01-26T07:39:06.000Z*
> Ayala Unit to Buy Majority Stake in Cold Storage Provider Megafridge

### [Ayala to Launch PHP30 Billion Shelf Registration for Bond Issue](https://longbridge.com/en/news/273335903.md)
*2026-01-22T07:30:34.000Z*
> Ayala to Launch PHP30 Billion Shelf Registration for Bond Issue

### [EXECUTIVE CHANGES: Genflow Biosciences names Berdugo as new chair](https://longbridge.com/en/news/272983903.md)
*2026-01-19T14:35:28.000Z*
> Genflow Biosciences has appointed Gad Berdugo as its new independent non-executive chair, effective immediately. Berdugo

### [OS Therapies Expands Pipeline With Ayala Asset Acquisition, Stock Up](https://longbridge.com/en/news/226594085.md)
*2025-01-29T15:58:22.000Z*
> OS Therapies, Inc. (OSTX) has announced an asset purchase agreement to acquire immuno-oncology programs and related IP f

### [OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostrate Cancer Programs to Pipeline | OSTX Stock News](https://longbridge.com/en/news/226583070.md)
*2025-01-29T14:22:00.000Z*
> OS Therapies, Inc. has agreed to acquire listeria monocytogenes-based immuno-oncology programs and IP assets from Ayala 

### [StockNews.com Initiates Coverage on Ayala Pharmaceuticals  ( NASDAQ:ADXS ) ](https://longbridge.com/en/news/208041149.md)
*2024-07-05T05:36:56.000Z*
> Analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS - Get Free Report ) in a res

### [StockNews.com Begins Coverage on Ayala Pharmaceuticals  ( NASDAQ:ADXS ) ](https://longbridge.com/en/news/206675784.md)
*2024-06-19T05:40:10.000Z*
> Research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS - Get Free Report )

### [Ayala Pharmaceuticals  ( NASDAQ:ADXS )  Coverage Initiated by Analysts at StockNews.com](https://longbridge.com/en/news/100550124.md)
*2023-10-23T08:03:04.000Z*
> Ayala Pharmaceuticals ( NASDAQ:ADXS ) Coverage Initiated by ...